ICD-10 C50.919 is a billable code used to specify a medical diagnosis of malignant neoplasm of unspecified site of unspecified female breast. The code is valid for the year 2019 for the submission of HIPAA-covered transactions.
You could go with C50.919 – malignant neoplasm of unspecified site, of unspecified female breast. That is an option but a better and the best option is C79.81 – secondary malignant neoplasm of the breast. I’m going to now explain why that’s the best choice. There’s a coding note that I found that’s really worded well, so I took it from that site.
What is ICD-10-CM, ICD-10-PCS, CPT, and HCPCS?
Disclosures: Kuwahara reports serving as a CMS fellow and previously served as a fellow at the Association of Asian Pacific Community Health Organizations. Disclosures: Kuwahara reports serving as a CMS fellow and previously served as a fellow at the Association of Asian Pacific Community Health Organizations.
Currently, there is no requirement for ICD-10-PCS training. Cancer registrars who don't maintain AHIMA credentials don't need ICD-10-specific credit hours, but it is strongly recommended that they familiarize themselves with the code set. Unfortunately, medical coder classes likely are more in-depth than what's necessary for registrars.
C50. 919 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C50. 919 became effective on October 1, 2021.
919 Malignant neoplasm of unspecified site of unspecified female breast.
N63. 0 - Unspecified lump in unspecified breast | ICD-10-CM.
ICD-10 code C50. 911 for Malignant neoplasm of unspecified site of right female breast is a medical classification as listed by WHO under the range - Malignant neoplasms .
ICD-10 code Z51. 11 for Encounter for antineoplastic chemotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
For example, Z12. 31 (Encounter for screening mammogram for malignant neoplasm of breast) is the correct code to use when you are ordering a routine mammogram for a patient. However, coders are coming across many routine mammogram orders that use Z12.
ICD-10 code: N64. 4 Mastodynia | gesund.bund.de.
ICD-10 code N63. 1 for Unspecified lump in the right breast is a medical classification as listed by WHO under the range - Diseases of the genitourinary system .
2022 ICD-10-CM Diagnosis Code N63: Unspecified lump in breast.
ICD-10 code Z85. 3 for Personal history of malignant neoplasm of breast is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
C50. 912 - Malignant neoplasm of unspecified site of left female breast | ICD-10-CM.
Breast Cancer ICD-10 Code Reference SheetPERSONAL OR FAMILY HISTORY*Z85.3Personal history of malignant neoplasm of breastZ80.3Family history of malignant neoplasm of breast
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
The 2022 edition of ICD-10-CM C50.919 became effective on October 1, 2021.
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
The 2022 edition of ICD-10-CM C50.912 became effective on October 1, 2021.
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. Malignant neoplasm of ectopic tissue. Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, ...
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
The 2022 edition of ICD-10-CM C50.911 became effective on October 1, 2021.
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
The 2022 edition of ICD-10-CM C50.011 became effective on October 1, 2021.
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as Z98.82. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
Z77-Z99 Persons with potential health hazards related to family and personal history and certain conditions influencing health status
The 2022 edition of ICD-10-CM Z98.82 became effective on October 1, 2021.